全文获取类型
收费全文 | 22979篇 |
免费 | 1488篇 |
国内免费 | 72篇 |
专业分类
耳鼻咽喉 | 363篇 |
儿科学 | 1211篇 |
妇产科学 | 549篇 |
基础医学 | 2213篇 |
口腔科学 | 391篇 |
临床医学 | 1807篇 |
内科学 | 5458篇 |
皮肤病学 | 350篇 |
神经病学 | 1234篇 |
特种医学 | 789篇 |
外国民族医学 | 3篇 |
外科学 | 4067篇 |
综合类 | 500篇 |
一般理论 | 6篇 |
预防医学 | 1327篇 |
眼科学 | 938篇 |
药学 | 1761篇 |
1篇 | |
中国医学 | 88篇 |
肿瘤学 | 1483篇 |
出版年
2023年 | 191篇 |
2022年 | 390篇 |
2021年 | 855篇 |
2020年 | 460篇 |
2019年 | 672篇 |
2018年 | 805篇 |
2017年 | 563篇 |
2016年 | 575篇 |
2015年 | 577篇 |
2014年 | 915篇 |
2013年 | 1125篇 |
2012年 | 1664篇 |
2011年 | 1539篇 |
2010年 | 952篇 |
2009年 | 782篇 |
2008年 | 1123篇 |
2007年 | 1164篇 |
2006年 | 1065篇 |
2005年 | 1026篇 |
2004年 | 898篇 |
2003年 | 753篇 |
2002年 | 686篇 |
2001年 | 548篇 |
2000年 | 565篇 |
1999年 | 460篇 |
1998年 | 179篇 |
1997年 | 149篇 |
1996年 | 133篇 |
1995年 | 129篇 |
1994年 | 114篇 |
1993年 | 96篇 |
1992年 | 299篇 |
1991年 | 274篇 |
1990年 | 236篇 |
1989年 | 228篇 |
1988年 | 185篇 |
1987年 | 194篇 |
1986年 | 172篇 |
1985年 | 177篇 |
1984年 | 153篇 |
1983年 | 149篇 |
1982年 | 77篇 |
1981年 | 88篇 |
1979年 | 129篇 |
1978年 | 90篇 |
1977年 | 68篇 |
1974年 | 77篇 |
1973年 | 111篇 |
1972年 | 104篇 |
1971年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
Exposure to electromagnetic fields and the risk of leukemia 总被引:4,自引:0,他引:4
K Sheikh 《Archives of environmental health》1986,41(1):56-63
Evidence from animal experiments and human studies suggests that electromagnetic fields may be human leukemogens. Epidemiological studies of leukemia in occupational groups and in the general populations are reviewed. The results are inconsistent. In the few studies showing an association between exposure to electromagnetic fields and the risk of leukemia, the temporal relationship between exposure and effect was not established, the observed associations were weak, the dose-response relationships were based on qualitative levels of exposure without regard to the duration of exposure or secondary sources of exposure, and the risk ratios were probably biased due to the population selection procedures used and misclassification of exposure. The proportionate mortality or cancer incidence ratios are unreliable estimates of relative risk. Further epidemiological research is needed to establish an association between exposure to electromagnetic fields and the risk of leukemia. 相似文献
23.
P M Doraiswamy K R Krishnan O B Boyko M M Husain G S Figiel V J Palese P R Escalona S A Shah W M McDonald W J Rockwell 《Progress in neuro-psychopharmacology & biological psychiatry》1991,15(3):351-356
1. The frequent occurrence of hypothalamo-pituitary dysfunction in patients with eating disorders as well as prior reports that nutritional and endocrine status influence pituitary morphology, led us to hypothesize that pituitary size and shape may be altered in patients with eating disorders. 2. Magnetic resonance imaging (MRI) does not use ionizing radiation and is currently one of the most feasible modalities available to study the pituitary gland in vivo. Using MRI, we have previously reported in a preliminary study that female patients with eating disorders had significantly smaller pituitary glands than controls. In addition MRI excluded any pituitary mass lesions. 3. In this report, we confirm our previous MRI findings and provide further evidence of pituitary abnormalities in an expanded sample of eating disorder patients. Preliminary data on pituitary volume estimates from MRI scans are provided for a subset of patients and controls. 相似文献
24.
Nauman A Chaudhry Alejandro J Lavaque Anish Shah Peter E Liggett 《Ophthalmic surgery, lasers & imaging》2005,36(1):70-72
The authors describe the use of photodynamic therapy with verteporfin for subfoveal choroidal neovascular membrane secondary to optic nerve drusen. A 28-year-old woman had a peripapillary choroidal neovascular membrane secondary to optic nerve drusen with significant metamorphopsia. Photodynamic therapy using verteporfin was performed. Visual acuity improved to 20/20 with resolution of metamorphopsia and absence of leakage on fluorescein angiography a few weeks after verteporfin therapy. The patient's condition remained stable for 16 months with 20/20 vision. Photodynamic therapy with verteporfin may be a useful treatment option in patients with choroidal neovascular membranes secondary to optic nerve drusen. 相似文献
25.
26.
Ramshekhar N. Menon Nirav Sanghani Mahendra Javali Neeraj Jain Arun B. Shah 《Annals of Indian Academy of Neurology》2009,12(1):40-44
We report an unusual case of sporadic adult onset cerebellar ataxia with hypogonadism. A 40-year-old unmarried man presented with progressive ataxia and dysarthria along with complaints of non-development of secondary sexual characteristics and erectile dysfunction. There were complaints of intermittent diarrhea. Clinical examination revealed a pan-cerebellar syndrome with features of hypoandrogenism. No eye movement abnormalities were evident. There were signs of malabsorption. Investigations confirmed the presence of auto-antibodies found in celiac disease, and a duodenal biopsy confirmed the same. Hypoandrogenism was postulated to be due to hypergonadotropic hypogonadism which has been mentioned in a few patients of celiac disease. However, the pattern seen in our patient was of a hypogonadotropic hypogonadism. This is probably secondary to an autoimmune hypophysitis seen in some patients in the absence of other clinical manifestations. Autoantibody testing should be a diagnostic necessity in any adult with a sporadic cerebellar ataxia. 相似文献
27.
Heiko Sch?der Diane L Carlson Dennis H Kraus Hilda E Stambuk Mithat G?nen Yusuf E Erdi Henry W D Yeung Andrew G Huvos Jatin P Shah Steven M Larson Richard J Wong 《Journal of nuclear medicine》2006,47(5):755-762
(18)F-FDG PET has a high accuracy in staging head and neck cancer, but its role in patients with clinically and radiographically negative necks (N0) is less clear. In particular, the value of combined PET/CT has not been determined in this group of patients. METHODS: In a prospective study, 31 patients with oral cancer and no evidence of lymph node metastases by clinical examination or CT/MRI underwent (18)F-FDG PET/CT before elective neck dissection. PET/CT findings were recorded by neck side (left or right) and lymph node level. PET/CT findings were compared with histopathology of dissected nodes, which was the standard of reference. RESULTS: Elective neck dissections (26 unilateral, 5 bilateral; a total of 36 neck sides), involving 142 nodal levels, were performed. Only 13 of 765 dissected lymph nodes harbored metastases. Histopathology revealed nodal metastases in 9 of 36 neck sides and 9 of 142 nodal levels. PET was TP in 6 nodal levels (6 neck sides), false-negative in 3 levels (3 neck sides), true-negative in 127 levels (23 neck sides), and false-positive in 6 levels (4 neck sides). The 3 false-negative findings occurred in metastases smaller than 3 mm or because of inability to distinguish between primary tumor and adjacent metastasis. TP and false-positive nodes exhibited similar standardized uptakes (4.8 +/- 1.1 vs. 4.2 +/- 1.0; P = not significant). Sensitivity and specificity were 67% and 85% on the basis of neck sides and 67% and 95% on the basis of number of nodal levels, respectively. If a decision regarding the need for neck dissection had been based solely on PET/CT, 3 false-negative necks would have been undertreated, and 4 false-positive necks would have been overtreated. CONCLUSION: (18)F-FDG PET/CT can identify lymph node metastases in a segment of patients with oral cancer and N0 neck. A negative test can exclude metastatic deposits with high specificity. Despite reasonably high overall accuracy, however, the clinical application of PET/CT in the N0 neck may be limited by the combination of limited sensitivity for small metastatic deposits and a relatively high number of false-positive findings. The surgical management of the N0 neck should therefore not be based on PET/CT findings alone. 相似文献
28.
Carla M Ward Peter J Zuromskis David V Ives Javed Sheikh 《Allergy and asthma proceedings》2007,28(3):382-387
There is a broad differential for patients presenting with fever, eosinophilia, and pneumonia. We present a case of a 48-year-old man who presented with recurrent fever, pleuritic chest pain, and cough. His medical history was significant for a recent trip to Arizona. A chest X ray showed a right lower lobe infiltrate and CT examination of the chest showed extensive mediastinal lymphadenopathy. Tissue culture from a biopsy specimen of the mediastinal lymph nodes revealed growth of Coccidioides immitis and a diagnosis of coccidioidomycosis was made. He was treated with a total of a 9-month course of itraconazole and has remained disease free for >2 years. This case shows how a careful history and evaluation will direct the clinician to the correct diagnosis. 相似文献
29.
目的观察JAK2激酶抑制剂AG490对结肠癌HT-29细胞侵袭以及对基质金属蛋白酶-2(MMP-2)表达的影响,探讨STAT3信号转导通路在结肠癌侵袭转移调控中的作用。方法应用JAK2激酶抑制剂AG490处理结肠癌HT-29细胞,Matrigel肿瘤体外侵袭模型检测肿瘤细胞侵袭;Western blot检测STAT3蛋白表达;逆转录-聚合酶链反应(RT—PCR)检测MMP2mRNA表达。结果AG490可抑制JAK2/STAT3信号转导通路活化及结肠癌HT-29细胞侵袭,在此过程中AG490在mRNA水平抑制MMP-2表达。结论STAT3信号转导通路参与结肠癌细胞侵袭调控,阻断STAT3通路活化可抑制结肠癌细胞侵袭,这一作用可能是通过抑制MMP-2表达实现的。 相似文献
30.
Practical management of patients with non-small-cell lung cancer treated with gefitinib. 总被引:7,自引:0,他引:7
Neelam T Shah Mark G Kris William Pao Leslie B Tyson Barbara M Pizzo Murk-Hein Heinemann Leah Ben-Porat Dana L Sachs Robert T Heelan Vincent A Miller 《Journal of clinical oncology》2005,23(1):165-174
PURPOSE: The use of gefitinib, the first drug approved to inhibit the epidermal growth factor receptor tyrosine kinase, is indicated in patients with non-small-cell lung cancer with tumors progressive after chemotherapy. The unique mechanism of action of this agent leads to distinctive patterns of response and toxicity in persons with lung cancer. Many of the principles of management relevant to gefitinib are distinct from those with conventional cytotoxic drugs. To meet this need, we present practical guidelines on the use of gefitinib in patients with non-small-cell lung cancer. METHODS: This article reviews gefitinib's indications, dosing, response phenomena, and patterns of relapse in individuals with radiographic response. RESULTS: We present our recommendations for the management of rash and diarrhea caused by this agent. CONCLUSION: This information can guide practitioners and help them inform their patients about what to expect when they receive gefitinib. 相似文献